Limitations on the discovery and supply of medicines.
作者信息
Weatherall M
出版信息
Proc R Soc Med. 1974 Dec;67(12 Pt 2):1287-92. doi: 10.1177/003591577406712P205.
Abstract
摘要
相似文献
1
Limitations on the discovery and supply of medicines.药品发现与供应方面的限制。
Proc R Soc Med. 1974 Dec;67(12 Pt 2):1287-92. doi: 10.1177/003591577406712P205.
2
Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976.
Eur J Clin Pharmacol. 1977 Mar 11;11(3):233-8.
3
Prescription drugs and the patient's health.处方药与患者健康。
Can Med Assoc J. 1974 Dec 7;111(11):1269 passim.
4
QUAD routes out inferior drugs.四方查处劣质药品。
Can Hosp. 1973 May;50(5):58-9.
5
[Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].[生物利用度、疗效证明及其对药品立法的影响（作者译）]
Arzneimittelforschung. 1976;26(1A):158-63.
6
Medicines, governments and doctors.药品、政府和医生。
Drugs. 1972;3(5):305-13. doi: 10.2165/00003495-197203050-00001.
7
The pharmaceutical industry: research and responsibility.制药行业：研究与责任。
Lancet. 1980 Aug 30;2(8192):465-6. doi: 10.1016/s0140-6736(80)91897-8.
8
Generic Pharmaceutical Industry Association Orphan Drug Institute.
Prog Clin Biol Res. 1985;197:41-5.
9
Minimum acceptable requirements for introduction and marketing of drugs.
Drugs. 1974;7(6):409-13. doi: 10.2165/00003495-197407060-00001.
10
Drug development, regulation, and the practice of medicine.药物研发、监管与医学实践。
JAMA. 1974 Sep 9;229(11):1457-61.
引用本文的文献
1
Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.亚急性脊髓-视神经神经病与氯碘羟喹。诊断的流行病学病例史。
Br J Prev Soc Med. 1975 Sep;29(3):157-69. doi: 10.1136/jech.29.3.157.
本文引用的文献
1
Future invention in a harsher world.在更严峻世界中的未来发明。
Proc R Soc Med. 1974 Oct;67(10):969-78. doi: 10.1177/003591577406701001.
2
Therapeutic implications of the drug lag.药物研发滞后的治疗意义。
Clin Pharmacol Ther. 1974 Jan;15(1):73-96. doi: 10.1002/cpt197415173.
Zotero 插件